Two research teams at Duke have received large, multi-year grants from the National Institutes of Health to pursue projects on HIV vaccine development.
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a five-year grant totaling more than $9 million to a team led by Mary Klotman, M.D., chair of the Department of Medicine at the Duke University School of Medicine.
The NIAID presented a second grant of more than $11 million over five years to a collaborative effort led by Sallie Permar, M.D., Ph.D., assistant professor in the Department of Pediatrics at Duke, and involving researchers at UNC and the University of California, Davis.
No comments:
Post a Comment